Orchid Cellmark Reports First Quarter 2008 Financi...(y be required by law. Information con...),Health

Information contained in our press releases should be considered accurate only as of the date of the release. Information in any press release may be superseded by more recent information we have disclosed in later press releases, filings with the Securities and Exchange Commission or otherwise. Press releases may contain forward-looking statements based on the expectations of our management as of the date of the release. Actual results may materially differ based on several factors, including those described in the press release.

Contacts

Investors: Media:

Mary Bashore Barbara Lindheim

Orchid Cellmark Inc. GendeLLindheim BioCom Partners

(609) 750-2324 (212) 918-4650

Orchid Cellmark Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

Three months ended March 31, 2008 and 2007

(In thousands, except per share data)

(Unaudited)

Three months ended

March 31,

2008 2007

Revenues:

Service revenues $14,395 $13,895

Other revenues 132 137

Total revenues 14,527 14,032

Operating expenses:

Cost of service revenues 10,436 9,519

Research and development 220 279

Marketing and sales 1,572 1,484

General and administrative 4,692 3,936

Amortization of intangible assets 477 445

Total operating ex
'/>"/>